| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/27/2002 | WO2001064713A3 Mammalian interleukin-10 (il-10) receptor variants |
| 06/27/2002 | WO2001061024A3 Rolling circle replicon expression vectors |
| 06/27/2002 | WO2001061020A3 Alteration of growth and adaptation under hypoxic conditions |
| 06/27/2002 | WO2001057186A3 Methods and compositions for diagnosis and treatment of cancer based on esf |
| 06/27/2002 | WO2001051672A3 System and method for controlling male fertility |
| 06/27/2002 | WO2001049847A9 26904, 38911, and 39404, seven-transmembrane proteins/g-protein coupled receptors |
| 06/27/2002 | WO2001044816B1 Conformational and topological protein regulation |
| 06/27/2002 | WO2001040277A3 Carbohydrate-aminated glycoproteins |
| 06/27/2002 | WO2001038358A9 Hbv/hcv virus-like particle |
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | WO2000078787A9 ISOLATED GENES FROM VIRULENT GROUP B $i(STREPTOCOCCUS AGALACTIAE) |
| 06/27/2002 | WO2000077238A9 Heterodimeric opioid g-protein coupled receptors |
| 06/27/2002 | WO2000077215A9 Cdc68p CHROMATIN REMODELING FACTOR |
| 06/27/2002 | WO2000071726A9 Methods to inhibit infectious agent transmission during xenotransplantation |
| 06/27/2002 | WO2000071561A9 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 06/27/2002 | WO2000069879A9 Ca7 cg04 gene |
| 06/27/2002 | WO2000064925A9 Method of inhibiting leukocyte adhesion to fibrinogen |
| 06/27/2002 | WO2000064920A9 Compositions, methods, and kits relating to resistin |
| 06/27/2002 | US20020083494 Genes regulating circadian clock function and photoperiodism |
| 06/27/2002 | US20020083489 DNA molecules and polypeptides of pseudomonas syringae Hrp pathogenicity island and their uses |
| 06/27/2002 | US20020083487 Nucleotide sequences which code transport proteins; for use in generating stress resistant plants |
| 06/27/2002 | US20020083485 Polynucleotide which codes protein; for use in generating stress resistant cells |
| 06/27/2002 | US20020083483 Regulatory sequences for use in contolling fertility in plants |
| 06/27/2002 | US20020083477 Treating nerve damage; administer insulin like growth factor isoform to human, monitor response of damaged nerves |
| 06/27/2002 | US20020082414 Membrane protein for use in controlling vasodilation |
| 06/27/2002 | US20020082413 PGC-1, a novel brown fat PPARgamma coactivator |
| 06/27/2002 | US20020082412 Methods |
| 06/27/2002 | US20020082411 Immune mediators and related methods |
| 06/27/2002 | US20020082410 Insulin promoter factor, and uses related thereto |
| 06/27/2002 | US20020082409 Stresscopins and their uses |
| 06/27/2002 | US20020082407 Novel human GABA receptors and polynucleotides encoding the same |
| 06/27/2002 | US20020082406 Novel human kinase interacting protein and polynucleotides encoding the same |
| 06/27/2002 | US20020082405 Novel human transporter proteins and polynucleotides encoding the same |
| 06/27/2002 | US20020082402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/27/2002 | US20020082401 Nucleotide sequences coding protein for use in treating eating disorder, autoimmune and viral diseases |
| 06/27/2002 | US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 06/27/2002 | US20020082395 Immunoglobulin for use in diagnosis, treatment and prevention of bacterial infections |
| 06/27/2002 | US20020082394 Treating a cancer; obtain polypeptide coded by tumor gene, administer to human, monitor human for reduction in tumors |
| 06/27/2002 | US20020082393 Polypeptides for use as wound healing agent and bactericide |
| 06/27/2002 | US20020082392 Antibodies to cell-cycle regulatory proteins, and uses related thereto |
| 06/27/2002 | US20020082391 Polypeptide; for use in enhancement of drug absorption across epithelial and endothelial barriers |
| 06/27/2002 | US20020082390 Novel human GABA transporter protein and polynucleotides encoding the same |
| 06/27/2002 | US20020082389 Method and means for site directed therapy |
| 06/27/2002 | US20020082388 Polypeptide for use in the treatment, diagnosis and prevention of cancer, nervous system and developmental disorders |
| 06/27/2002 | US20020082387 Novel proline-rich membrane protein |
| 06/27/2002 | US20020082386 Monoclonal antibody for use in the detecion and prevention of bacillus anthracis infections |
| 06/27/2002 | US20020082385 Protein for use in dietetics and the treatment of diabebtes |
| 06/27/2002 | US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/27/2002 | US20020082232 Transgenic mice containing NPY6-R neuropeptide receptor gene disruptions |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082229 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 06/27/2002 | US20020082224 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 06/27/2002 | US20020082219 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/27/2002 | US20020082217 Synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes |
| 06/27/2002 | US20020082215 Administering to nasal cavity of mammal a pharmaceutical composition comprising therapeutically effective amount of insulin-like growth factor-I or biologically active variant thereof |
| 06/27/2002 | US20020082214 Alpha 1-antitrypsin preparation as well as a method for producing the same |
| 06/27/2002 | US20020082211 Human presenilin variant |
| 06/27/2002 | US20020082210 Nucleic acid molecules which encode novel ion channel members; medical diagnosis |
| 06/27/2002 | US20020082207 Comprising pancreatic tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, T cells specific for cells expressing such polypeptides |
| 06/27/2002 | US20020082206 Nucleic acids that include open reading frames encoding novel polypeptides; antiinflammatory, antitumor agents |
| 06/27/2002 | US20020082205 Human FGF-23 gene and gene expression products |
| 06/27/2002 | US20020082202 Screening methods using ligands of the neutropeptide receptor HFGAN72 |
| 06/27/2002 | US20020082199 Insoluble insulin compositions |
| 06/27/2002 | US20020082196 Peptides with physiological activity |
| 06/27/2002 | US20020082192 Contacting cell with compound that activates extracellular signal regulated kinase, p42/44MAPK, wherein activation of kinase results in induction of low density lipoprotein receptor expression; treatment of hypercholesterolemia |
| 06/27/2002 | US20020082191 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020082190 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020081735 Of given nucleotide sequence, operably linked to a DNA sequence encoding a structural gene |
| 06/27/2002 | US20020081734 Modified muteins of erythropoietin derived from in vitro or in vivo expression system of microorganism |
| 06/27/2002 | US20020081733 Method to prepare drug-resistant, non-malignant hematopoietic cells |
| 06/27/2002 | US20020081732 Electroprocessing in drug delivery and cell encapsulation |
| 06/27/2002 | US20020081730 HVD1 gene induced by salt stress |
| 06/27/2002 | US20020081722 Nucleotide sequences coding preferential polypeptide for use in treatment and prevention of bacterial infection |
| 06/27/2002 | US20020081720 Receptor activator of NF-kappaB |
| 06/27/2002 | US20020081719 Inflammation inducible hybrid promoters, vectors comprising them and uses thereof |
| 06/27/2002 | US20020081718 Polypeptide, and a dna sequence to which a protein containing the polypetide binds |
| 06/27/2002 | US20020081711 Expression vector for use in the reatment of solid tumors |
| 06/27/2002 | US20020081709 Expression vector for use as tool in genetic engineering |
| 06/27/2002 | US20020081706 Negative strand rna viral vector having autonomous replication capability |
| 06/27/2002 | US20020081701 Nucleotide sequences coding proteins for use in the treatment of microorganismal infections |
| 06/27/2002 | US20020081700 Polynucleotide encoding protein for use as tool in evaluating cell and tissue development |
| 06/27/2002 | US20020081698 Nucleotide sequences which code polypeptide for use in treatment of blood disorders |
| 06/27/2002 | US20020081696 32529, a novel human guanine nucleotide exchange factor family member and uses thereof |
| 06/27/2002 | US20020081690 Hybrid enzyme and use thereof |
| 06/27/2002 | US20020081688 Retinoid pathway assays, and compositions therefrom |
| 06/27/2002 | US20020081687 Sitosterolemia susceptibility gene (SSG): compositions and methods of use |
| 06/27/2002 | US20020081685 Disintegrin homologs, ZSNK10, ZSNK11, and ZSNK12 |
| 06/27/2002 | US20020081684 Method and nucleotide sequence for transforming microorganisms |
| 06/27/2002 | US20020081683 Polypeptide for use in the diagnosis and treatment of psoriasis, infection, asthma and immune and respiratory disorders |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081680 Fusion protein for use in the diagnosis and treatment of tumors |
| 06/27/2002 | US20020081679 NARC8 programmed cell-death-associated molecules and uses thereof |
| 06/27/2002 | US20020081678 Isolated nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/27/2002 | US20020081674 Nucleotide sequences coding enzymatic polypeptide for generation of lysine and valine for use in human medicine and animal nutrients |
| 06/27/2002 | US20020081673 Polynucleotide sequences which code enzymatic polypeptide for use in generation of lysine for human medicines and animal nutrients |
| 06/27/2002 | US20020081672 Nucleotide sequences coding enzymatic polypeptide for use in generation of lysine for foods, medicines and animal nutrients |
| 06/27/2002 | US20020081665 Composition for use as immunomodulatory and anticarcinogenic agents |
| 06/27/2002 | US20020081664 Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 06/27/2002 | US20020081663 Polypeptide for use as wound healing agent |
| 06/27/2002 | US20020081661 DNA encoding 5-HT4 serotonin receptors and uses thereof |